October 7th, 2025 | 07:45 CEST
Aspermont, Palantir, RENK – AI sets the pace. Where is the next run?
International stock markets are booming. The Dow Jones recently surpassed 47,000 points, seemingly unaffected by the US government shutdown. The topic of artificial intelligence (AI) continues to be the focus of investor interest, and recent company announcements are causing a stir. Japanese electronics giant Hitachi and ChatGPT provider OpenAI are partnering to build AI infrastructure and global data centers. Meanwhile, Fujitsu and leading AI chip manufacturer Nvidia are expanding their collaboration and plan to jointly develop a platform that uses AI in a targeted manner for specific industries, such as healthcare and robotics. In view of the AI boom, it is becoming increasingly compelling to explore second- and third-tier stocks that could benefit from the surge in innovation and investor interest.
time to read: 3 minutes
|
Author:
Carsten Mainitz
ISIN:
ASPERMONT LTD | AU000000ASP3 , PALANTIR TECHNOLOGIES INC | US69608A1088 , RENK AG O.N. | DE000RENK730
Table of contents:
"[...] In Canada, there is $1.75 of debt for every dollar of disposable income - and that was true even before the pandemic. [...]" Karim Nanji, CEO, Marble Financial
Author
Carsten Mainitz
The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.
Tag cloud
Shares cloud
Aspermont – An overlooked AI player!
One little-noticed second-tier stock with AI power is Aspermont. The Australian company, with extensive expertise in commodities, has undergone an impressive digital transformation, evolving from a traditional media company into a media and data technology firm. However, this development has largely gone unnoticed by the market - a promising opportunity for savvy investors.
Aspermont has a huge global community of over 3.8 million professionals. Its core business is based on a scalable subscription model that delivers Content as a Service (CaaS). The offering is rounded off with events and various marketing solutions.
The latest strategic move with the introduction of the Mining IQ AI platform could be a game changer, as Aspermont possesses a significant unique selling point. This is a one-of-a-kind digital data archive comprising over two centuries of expertise. Historical editions of renowned publications, such as the Mining Journal, have been digitized and made searchable. This unparalleled data collection provides in-depth and valuable insights into market cycles, technology trends, and project developments.
Industry heavyweight Rio Tinto also recognized this potential and secured exclusive access for six months. The monetization potential of this data treasure trove, combined with the accolade of such a major global player, should make investors aware of the stock's significant upside. So far, the market has not yet priced in the AI potential, with the Company's market capitalization currently standing at around AUD 16 million. According to GBC analysts, the stock could be a multiplier.
Palantir – AI for the healthcare sector too
Palantir Technologies specializes in the development and marketing of software platforms for big data analysis, data integration and management, and other solutions. Essentially, customers are provided with tools that enable them to gain strategic insights from their raw, unstructured data sets. Government agencies and companies, primarily US-based firms, use these platforms.
Most recently, news from the defense sector has caught our attention. Boeing's defense division announced its intention to adopt Palantir's solutions for data-driven management of its production facilities and military programs. In addition, the Company revealed the strengthening of its partnership with the British Ministry of Defence.
The recent announcement that a five-year contract had been signed with OneMedNet Corporation to fundamentally change the market for AI in healthcare and real-world data (RWD) analysis provided a positive boost for the stock. Palantir's software is used to offer life sciences organizations the most up-to-date data, reducing costs and time to market for novel healthcare solutions.
RENK – Norwegian sovereign wealth fund reduces stake near all-time high!
Hats off! The Norwegian sovereign wealth fund continues to demonstrate impressive timing and stock-picking skills. The fund began building a position in RENK at below EUR 20 per share. A few days ago, their stake reached 3.27%, but the latest announcement reveals a reduction to 2.94%. This means that the sale occurred close to the all-time high of EUR 90, where RENK shares are currently trading, giving the Company a market capitalization of nearly EUR 9 billion.
RENK is a leading global manufacturer of mission-critical drive solutions in various military and civilian end markets. Digitalization, automation, and smart systems play an increasingly important role. In July, the Company announced a strategic partnership with start-up ARX Robotics to develop autonomous mobility solutions, including unmanned ground vehicles. RENK also integrates algorithms, machine learning, and AI components in the areas of monitoring and diagnostic systems to predict deviations, failures, and wear-and-tear.
AI and data analysis as a competitive advantage
Intelligent data analysis is often the key to competitive advantages. Palantir demonstrates this impressively. Companies such as RENK are forming partnerships to secure the relevant expertise. Aspermont, on the other hand, sits on a treasure trove of data that now offers customers unparalleled added value through the use of AI. The stock is still flying under the radar of the broad investor base. Get in before it is too late.
Conflict of interest
Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.
In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.
For this reason, there is a concrete conflict of interest.
The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.
Risk notice
Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.
The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.
The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.
